Skip to main content

01.07.2012 | Original Paper

Adherence to guideline excision margins in head and neck melanoma: the influence on 5-year survival and loco-regional recurrence

verfasst von: Gregory A. J. Robertson, Bernard F. Robertson, Michael Senior, Elisabeth Zetlitz, Taimur Shoaib

Erschienen in: European Journal of Plastic Surgery | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Guidelines for the management of cutaneous melanoma suggest wide local excision of increasing margins for increasing Breslow thickness of the primary neoplasm. These guidelines are based on randomized controlled trial data from limb and trunk melanoma studies. We performed retrospective analysis of our institution's head and neck melanoma database to investigate the effect of narrow excision margins on survival and loco-regional recurrence. We identified 101 patients with node-negative head and neck melanoma from 1993 to 2001 who had prospectively gathered data. The overall 5-year loco-regional recurrence rate (LR) was 37%. The overall 5-year melanoma-specific survival rate (5y.s.) was 70%. When guidelines were followed (n = 36), LR was 19% and 5y.s. was 89%. When guidelines were not followed (n = 65), LR was 46% and 5y.s. was 60%. On univariate analysis, we found scalp location (p < 0.001), male gender (p < 0.025), advanced tumour T stage (p < 0.005) and non-adherence to guidelines (p < 0.003) were significantly associated with poorer 5y.s., whilst scalp location (p < 0.004), advanced tumour T stage (p < 0.030) and non-adherence to guidelines (p < 0.010) were significantly associated with greater LR. On multivariate analysis, only scalp location (p < 0.001; p < 0.001) and advanced tumour T stage (p < 0.020; p < 0.014) remained significant predictors of 5y.s. and LR. We conclude it is often impossible to perform excision margins as recommended in published guidelines for cutaneous melanoma in the head and neck, given functional and aesthetic constraints. While such margins should be adhered to where possible, adherence is not the major factor in long-term recurrence and survival (level of evidence: IV).
Literatur
1.
Zurück zum Zitat MacKie RM, Bray C, Vestey J, Doherty V, Evans A, Thomson D, Nicolson M, Group SM (2007) Melanoma incidence and mortality in Scotland 1979–2003. Br J Cancer 4(96):1772–1777CrossRef MacKie RM, Bray C, Vestey J, Doherty V, Evans A, Thomson D, Nicolson M, Group SM (2007) Melanoma incidence and mortality in Scotland 1979–2003. Br J Cancer 4(96):1772–1777CrossRef
2.
Zurück zum Zitat Hoersch B, Leiter U, Garbe C (2006) Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol 155:771–777PubMedCrossRef Hoersch B, Leiter U, Garbe C (2006) Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol 155:771–777PubMedCrossRef
3.
Zurück zum Zitat Stadelmann WK, McMasters K, Digenis AG, Reintgen DS (2000) Cutaneous melanoma of the head and neck: advances in evaluation and treatment. Plast Reconstr Surg 105:2105–2126PubMedCrossRef Stadelmann WK, McMasters K, Digenis AG, Reintgen DS (2000) Cutaneous melanoma of the head and neck: advances in evaluation and treatment. Plast Reconstr Surg 105:2105–2126PubMedCrossRef
4.
Zurück zum Zitat Ringborg U, Afzelius LE, Lagerlöf B et al (1993) Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer 1(71):751–758CrossRef Ringborg U, Afzelius LE, Lagerlöf B et al (1993) Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer 1(71):751–758CrossRef
5.
Zurück zum Zitat Fisher SR (1989) Cutaneous malignant melanoma of the head and neck. Laryngoscope 99:822–836PubMedCrossRef Fisher SR (1989) Cutaneous malignant melanoma of the head and neck. Laryngoscope 99:822–836PubMedCrossRef
6.
Zurück zum Zitat Urist MM, Balch CM, Soong SJ et al (1984) Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 200:769–775PubMedCrossRef Urist MM, Balch CM, Soong SJ et al (1984) Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 200:769–775PubMedCrossRef
7.
Zurück zum Zitat Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL (1988) Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer 15(62):831–837CrossRef Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL (1988) Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer 15(62):831–837CrossRef
8.
Zurück zum Zitat Wenzel S, Metternich FU, Sagowski C, Neuber K, Kehrl W (2001) Cutaneous malignant melanoma in the area of the head and neck with intermediate tumour thickness: does primary site have prognostic relevance? Laryngorhinootologie 80:313–317PubMedCrossRef Wenzel S, Metternich FU, Sagowski C, Neuber K, Kehrl W (2001) Cutaneous malignant melanoma in the area of the head and neck with intermediate tumour thickness: does primary site have prognostic relevance? Laryngorhinootologie 80:313–317PubMedCrossRef
9.
Zurück zum Zitat Narayan D, Ariyan S (2001) Surgical considerations in the management of malignant melanoma of the ear. Plast Reconstr Surg 107:20–24PubMedCrossRef Narayan D, Ariyan S (2001) Surgical considerations in the management of malignant melanoma of the ear. Plast Reconstr Surg 107:20–24PubMedCrossRef
10.
Zurück zum Zitat O'Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, McCarthy WH (1991) Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 162:310–314PubMedCrossRef O'Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, McCarthy WH (1991) Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 162:310–314PubMedCrossRef
11.
Zurück zum Zitat Eggermont A, Autier P, Keilholz U (2002) Cutaneous malignant melanoma. In: Souhamin R, Tannock I, Hohenberger P, Horiet JC (eds) Oxford textbook of oncology, 2nd edn. Oxford University, Oxford, pp 1175–1211 Eggermont A, Autier P, Keilholz U (2002) Cutaneous malignant melanoma. In: Souhamin R, Tannock I, Hohenberger P, Horiet JC (eds) Oxford textbook of oncology, 2nd edn. Oxford University, Oxford, pp 1175–1211
12.
Zurück zum Zitat Sladden MJ, Balch C, Barzilai DA et al (2009) Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 7:CD004835 Sladden MJ, Balch C, Barzilai DA et al (2009) Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 7:CD004835
14.
Zurück zum Zitat Marsden JR, Newton-Bishop JA, Burrows L et al (2010) British Association of Dermatologists (BAD) Clinical Standards Unit. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 63:1401–1419PubMedCrossRef Marsden JR, Newton-Bishop JA, Burrows L et al (2010) British Association of Dermatologists (BAD) Clinical Standards Unit. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 63:1401–1419PubMedCrossRef
15.
Zurück zum Zitat Livingstone E, Windemuth-Kieselbach C, Eigentler TK et al (2011) A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer 47:1977–1989PubMedCrossRef Livingstone E, Windemuth-Kieselbach C, Eigentler TK et al (2011) A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer 47:1977–1989PubMedCrossRef
16.
Zurück zum Zitat Sullivan SR, Scott JR, Cole JK et al (2009) Head and neck malignant melanoma: margin status and immediate reconstruction. Ann Plast Surg 62:144–148PubMedCrossRef Sullivan SR, Scott JR, Cole JK et al (2009) Head and neck malignant melanoma: margin status and immediate reconstruction. Ann Plast Surg 62:144–148PubMedCrossRef
17.
Zurück zum Zitat Erickson JL, Velasco JM, Hieken TJ (2008) Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables. Ann Surg Oncol 15:1211–1217PubMedCrossRef Erickson JL, Velasco JM, Hieken TJ (2008) Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables. Ann Surg Oncol 15:1211–1217PubMedCrossRef
18.
Zurück zum Zitat Haniff J, de Vries E, Claassen AT, Looman CW, van Berlo Ch, Coebergh JW (2006) Non-compliance with the re-excision guidelines for cutaneous melanoma in The Netherlands does not influence survival. Eur J Surg Oncol 32:85–89PubMedCrossRef Haniff J, de Vries E, Claassen AT, Looman CW, van Berlo Ch, Coebergh JW (2006) Non-compliance with the re-excision guidelines for cutaneous melanoma in The Netherlands does not influence survival. Eur J Surg Oncol 32:85–89PubMedCrossRef
19.
Zurück zum Zitat Thomas JM, Newton-Bishop J, A'Hern R, United Kingdom Melanoma Study Group, British Association of Plastic Surgeons, Scottish Cancer Therapy Network et al (2004) Excision margins in high-risk malignant melanoma. N Engl J Med 19(350):757–766CrossRef Thomas JM, Newton-Bishop J, A'Hern R, United Kingdom Melanoma Study Group, British Association of Plastic Surgeons, Scottish Cancer Therapy Network et al (2004) Excision margins in high-risk malignant melanoma. N Engl J Med 19(350):757–766CrossRef
20.
Zurück zum Zitat Balch CM, Soong SJ, Smith T, Investigators from the Intergroup Melanoma Surgical Trial et al (2001) Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 8:101–108PubMed Balch CM, Soong SJ, Smith T, Investigators from the Intergroup Melanoma Surgical Trial et al (2001) Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 8:101–108PubMed
21.
Zurück zum Zitat Vossaert KA, Silverman MK, Kopf AW, Bart RS, Rigel DS, Friedman RJ, Levenstein M (1992) Influence of gender on survival in patients with stage I malignant melanoma. J Am Acad Dermatol 26:429–440PubMedCrossRef Vossaert KA, Silverman MK, Kopf AW, Bart RS, Rigel DS, Friedman RJ, Levenstein M (1992) Influence of gender on survival in patients with stage I malignant melanoma. J Am Acad Dermatol 26:429–440PubMedCrossRef
22.
Zurück zum Zitat Medina JE, Ferlito A, Brandwein MS et al (2002) Current management of cutaneous malignant melanoma of the head and neck. Acta Otolaryngol 122:900–906PubMedCrossRef Medina JE, Ferlito A, Brandwein MS et al (2002) Current management of cutaneous malignant melanoma of the head and neck. Acta Otolaryngol 122:900–906PubMedCrossRef
23.
Zurück zum Zitat Gillgren P, Månsson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U (2000) A prospective population-based study of cutaneous malignant melanoma of the head and neck. Laryngoscope 110:1498–1504PubMedCrossRef Gillgren P, Månsson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U (2000) A prospective population-based study of cutaneous malignant melanoma of the head and neck. Laryngoscope 110:1498–1504PubMedCrossRef
24.
25.
Zurück zum Zitat Gussack GS, Reintgen D, Cox E et al (1983) Cutaneous melanoma of the head and neck. A review of 399 cases. Arch Otolaryngol 109:803–808PubMedCrossRef Gussack GS, Reintgen D, Cox E et al (1983) Cutaneous melanoma of the head and neck. A review of 399 cases. Arch Otolaryngol 109:803–808PubMedCrossRef
26.
Zurück zum Zitat Kane WJ, Yugueros P, Clay RP, Woods JE (1997) Treatment outcome for 424 primary cases of clinical I cutaneous malignant melanoma of the head and neck. Head Neck 19:457–465PubMedCrossRef Kane WJ, Yugueros P, Clay RP, Woods JE (1997) Treatment outcome for 424 primary cases of clinical I cutaneous malignant melanoma of the head and neck. Head Neck 19:457–465PubMedCrossRef
27.
Zurück zum Zitat Cox NH, Aitchison TC, Sirel JM, MacKie RM (1996) Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. Br J Cancer 73:940–944PubMedCrossRef Cox NH, Aitchison TC, Sirel JM, MacKie RM (1996) Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. Br J Cancer 73:940–944PubMedCrossRef
28.
Zurück zum Zitat Hudson DA, Krige JE, Grobbelaar AO, Morgan B, Grover R (1998) Melanoma of the face: the safety of narrow excision margins. Scand J Plast Reconstr Hand Surg 32:97–104CrossRef Hudson DA, Krige JE, Grobbelaar AO, Morgan B, Grover R (1998) Melanoma of the face: the safety of narrow excision margins. Scand J Plast Reconstr Hand Surg 32:97–104CrossRef
29.
Zurück zum Zitat Andersson AP, Gottlieb J, Drzewiecki KT, Hou-Jensen K, Sondergaard K (1992) Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients. Cancer 1(69):1153–1156 Andersson AP, Gottlieb J, Drzewiecki KT, Hou-Jensen K, Sondergaard K (1992) Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients. Cancer 1(69):1153–1156
30.
Zurück zum Zitat Lens MB, Nathan P, Bataille V (2007) Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg 142:885–893PubMedCrossRef Lens MB, Nathan P, Bataille V (2007) Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg 142:885–893PubMedCrossRef
31.
Zurück zum Zitat Erickson Foster J, Velasco JM, Hieken TJ (2008) Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol 15:2395–2402PubMedCrossRef Erickson Foster J, Velasco JM, Hieken TJ (2008) Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol 15:2395–2402PubMedCrossRef
32.
Zurück zum Zitat McKinnon JG, Starritt EC, Scolyer RA, McCarthy WH, Thompson JF (2005) Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick. Ann Surg 241:326–333PubMedCrossRef McKinnon JG, Starritt EC, Scolyer RA, McCarthy WH, Thompson JF (2005) Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick. Ann Surg 241:326–333PubMedCrossRef
33.
Zurück zum Zitat Haigh PI, DiFronzo LA, McCready DR (2003) Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 46:419–426PubMed Haigh PI, DiFronzo LA, McCready DR (2003) Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 46:419–426PubMed
34.
Zurück zum Zitat Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902–908PubMedCrossRef Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902–908PubMedCrossRef
35.
Zurück zum Zitat Soong SJ, Ding S, Coit D, Balch CM, Gershenwald JE, Thompson JF, Gimotty P, AJCC Melanoma Task Force (2010) Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Ann Surg Oncol 17:2006–2014PubMedCrossRef Soong SJ, Ding S, Coit D, Balch CM, Gershenwald JE, Thompson JF, Gimotty P, AJCC Melanoma Task Force (2010) Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Ann Surg Oncol 17:2006–2014PubMedCrossRef
36.
Zurück zum Zitat Rogers GS, Kopf AW, Rigel DS et al (1983) Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Arch Dermatol 119:644–649PubMedCrossRef Rogers GS, Kopf AW, Rigel DS et al (1983) Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Arch Dermatol 119:644–649PubMedCrossRef
Metadaten
Titel
Adherence to guideline excision margins in head and neck melanoma: the influence on 5-year survival and loco-regional recurrence
verfasst von
Gregory A. J. Robertson
Bernard F. Robertson
Michael Senior
Elisabeth Zetlitz
Taimur Shoaib
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Plastic Surgery / Ausgabe 7/2012
Print ISSN: 0930-343X
Elektronische ISSN: 1435-0130
DOI
https://doi.org/10.1007/s00238-011-0668-9

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.